Literature DB >> 27992410

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

Fangfang Chen1,2, Guankui Wang2, James I Griffin2, Barbara Brenneman2, Nirmal K Banda3, V Michael Holers3, Donald S Backos4, LinPing Wu5, Seyed Moein Moghimi5,6,7, Dmitri Simberg2.   

Abstract

When nanoparticles are intravenously injected into the body, complement proteins deposit on the surface of nanoparticles in a process called opsonization. These proteins prime the particle for removal by immune cells and may contribute toward infusion-related adverse effects such as allergic responses. The ways complement proteins assemble on nanoparticles have remained unclear. Here, we show that dextran-coated superparamagnetic iron oxide core-shell nanoworms incubated in human serum and plasma are rapidly opsonized with the third complement component (C3) via the alternative pathway. Serum and plasma proteins bound to the nanoworms are mostly intercalated into the nanoworm shell. We show that C3 covalently binds to these absorbed proteins rather than the dextran shell and the protein-bound C3 undergoes dynamic exchange in vitro. Surface-bound proteins accelerate the assembly of the complement components of the alternative pathway on the nanoworm surface. When nanoworms pre-coated with human plasma were injected into mice, C3 and other adsorbed proteins undergo rapid loss. Our results provide important insight into dynamics of protein adsorption and complement opsonization of nanomedicines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27992410      PMCID: PMC5617637          DOI: 10.1038/nnano.2016.269

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


  59 in total

1.  Accurate calculation of the density of proteins.

Authors:  M L Quillin; B W Matthews
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-07

2.  Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.

Authors:  Caroline Lemarchand; Ruxandra Gref; Catherine Passirani; Emmanuel Garcion; Boris Petri; Rainer Müller; Dominique Costantini; Patrick Couvreur
Journal:  Biomaterials       Date:  2006-01       Impact factor: 12.479

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 4.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

5.  Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead.

Authors:  S M Moghimi; A J Andersen; S H Hashemi; B Lettiero; D Ahmadvand; A C Hunter; T L Andresen; I Hamad; J Szebeni
Journal:  J Control Release       Date:  2010-04-11       Impact factor: 9.776

6.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

7.  Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake.

Authors:  Beatriz Pelaz; Pablo del Pino; Pauline Maffre; Raimo Hartmann; Marta Gallego; Sara Rivera-Fernández; Jesus M de la Fuente; G Ulrich Nienhaus; Wolfgang J Parak
Journal:  ACS Nano       Date:  2015-06-25       Impact factor: 15.881

8.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Authors:  Anna Salvati; Andrzej S Pitek; Marco P Monopoli; Kanlaya Prapainop; Francesca Baldelli Bombelli; Delyan R Hristov; Philip M Kelly; Christoffer Åberg; Eugene Mahon; Kenneth A Dawson
Journal:  Nat Nanotechnol       Date:  2013-01-20       Impact factor: 39.213

9.  The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.

Authors:  G Borchard; J Kreuter
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

10.  Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

Authors:  I Hamad; A C Hunter; J Szebeni; S M Moghimi
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

View more
  98 in total

1.  Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

Authors:  Hanmant Gaikwad; Yue Li; Geoffrey Gifford; Ernest Groman; Nirmal K Banda; Laura Saba; Robert Scheinman; Guankui Wang; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2020-06-29       Impact factor: 4.774

Review 2.  Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function.

Authors:  Rebecca L Pinals; Linda Chio; Francis Ledesma; Markita P Landry
Journal:  Analyst       Date:  2020-07-01       Impact factor: 4.616

3.  Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II.

Authors:  Guankui Wang; Natalie J Serkova; Ernest V Groman; Robert I Scheinman; Dmitri Simberg
Journal:  Mol Pharm       Date:  2019-09-26       Impact factor: 4.939

Review 4.  Nanoparticle Interactions with the Tumor Microenvironment.

Authors:  Yanyan Huai; Md Nazir Hossen; Stefan Wilhelm; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  Bioconjug Chem       Date:  2019-09-05       Impact factor: 4.774

Review 5.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

6.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Authors:  Peter Popp Wibroe; Aaron C Anselmo; Per H Nilsson; Apoorva Sarode; Vivek Gupta; Rudolf Urbanics; Janos Szebeni; Alan Christy Hunter; Samir Mitragotri; Tom Eirik Mollnes; Seyed Moein Moghimi
Journal:  Nat Nanotechnol       Date:  2017-04-10       Impact factor: 39.213

7.  Formation of a protein corona influences the biological identity of nanomaterials.

Authors:  Daniel Nierenberg; Annette R Khaled; Orielyz Flores
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-28

8.  Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.

Authors:  Geoffrey Gifford; Vivian P Vu; Nirmal K Banda; V Michael Holers; Guankui Wang; Ernest V Groman; Donald Backos; Robert Scheinman; S Moein Moghimi; Dmitri Simberg
Journal:  J Control Release       Date:  2019-04-08       Impact factor: 9.776

9.  Complement activation turnover on surfaces of nanoparticles.

Authors:  S M Moghimi; D Simberg
Journal:  Nano Today       Date:  2017-04-12       Impact factor: 20.722

10.  One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility.

Authors:  Raziye Mohammadpour; Darwin L Cheney; Jason W Grunberger; Mostafa Yazdimamaghani; Jolanta Jedrzkiewicz; Kyle J Isaacson; Marina A Dobrovolskaia; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2020-05-25       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.